Physician
American Multispecialty Group INC.
American Multispecialty Group INC. was paid $2.56M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoAMERICAN MULTISPECIALTY GROUP INC.
SAINT LOUIS, MO 63141
SAINT LOUIS, MO 63141
33aNPI1972559532assigned 05/25/2006
33bProvider typePediatrics Physician
28Total paid$2.56M
24GClaims38,475
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Missouri
Rank by total paid#10 of 992
Median peer was paid$40K
This provider vs. median63×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 414 | $9K | |
| 2019 | 88 | $2K | |
| 2020 | 3,647 | $230K | |
| 2021 | 7,657 | $513K | |
| 2022 | 9,684 | $651K | |
| 2023 | 9,580 | $668K | |
| 2024incomplete | 7,405 | $486K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 10,577 | 9,374 | $888K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 10,743 | 9,852 | $667K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 19% | 2,173 | 2,127 | $498K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 870 | 869 | $88K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 601 | 597 | $66K |
| 95117 | 2.4% | 5,603 | 2,112 | $62K | |
| 90686 | 1.9% | 2,011 | 1,994 | $49K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 743 | 721 | $44K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 396 | 395 | $40K |
| 92551 | 1.0% | 663 | 652 | $26K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 184 | 179 | $25K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 485 | 471 | $17K |
26 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 895 | $14K |
| 92587 | <1% | 365 | $12K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 125 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 583 | $9K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 96 | $9K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 350 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 168 | $6K |
| 90656 | <1% | 204 | $5K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 39 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $935.56 |
| 90651 | <1% | 100 | $845.40 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 33 | $720.85 |
| 87807 | <1% | 56 | $719.30 | |
| 90734 | <1% | 29 | $712.82 | |
| 90670 | <1% | 27 | $639.08 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 19 | $636.40 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $539.92 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $469.80 |
| 90700 | <1% | 12 | $294.96 | |
| 90619 | <1% | 24 | $242.16 | |
| 90620 | <1% | 26 | $221.54 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12 | $200.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 126 | $156.54 |
| 90677 | <1% | 14 | $141.26 | |
| 85018 | <1% | 24 | $56.64 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 57 | $35.54 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEARNEY, DAVID (CEO)